Pages that link to "Q36997418"
Jump to navigation
Jump to search
The following pages link to The molecular functions of Shp2 in the Ras/Mitogen-activated protein kinase (ERK1/2) pathway (Q36997418):
Displaying 50 items.
- Molecular Basis of Signaling Specificity of Insulin and IGF Receptors: Neglected Corners and Recent Advances (Q21131281) (← links)
- Signal regulatory protein alpha (SIRPalpha)/CD47 interaction and function (Q24598828) (← links)
- Emerging roles for IL-11 signaling in cancer development and progression: Focus on breast cancer (Q26799622) (← links)
- Structural and functional properties of platelet-derived growth factor and stem cell factor receptors (Q26829546) (← links)
- Small G proteins in the cardiovascular system: physiological and pathological aspects (Q27010607) (← links)
- Neuroblastoma tyrosine kinase signaling networks involve FYN and LYN in endosomes and lipid rafts (Q27319837) (← links)
- Molecular Basis of Gain-of-Function LEOPARD Syndrome-Associated SHP2 Mutations (Q27684353) (← links)
- Tyrosine phosphatase SHP2 regulates the expression of acyl-CoA synthetase ACSL4 (Q28247569) (← links)
- Cannabinoid 1 receptor and interleukin-6 receptor together induce integration of protein kinase and transcription factor signaling to trigger neurite outgrowth (Q28566936) (← links)
- Inhibitors of Src homology-2 domain containing protein tyrosine phosphatase-2 (Shp2) based on oxindole scaffolds (Q33357659) (← links)
- Sprouty2-modulated Kras signaling rescues Shp2 deficiency during lens and lacrimal gland development (Q33714226) (← links)
- Critical Role of IRF-8 in Negative Regulation of TLR3 Expression by Src Homology 2 Domain-Containing Protein Tyrosine Phosphatase-2 Activity in Human Myeloid Dendritic Cells (Q33739576) (← links)
- Global phosphoproteomics reveals crosstalk between Bcr-Abl and negative feedback mechanisms controlling Src signaling (Q33753325) (← links)
- Noonan syndrome: clinical aspects and molecular pathogenesis (Q33806161) (← links)
- Small molecule inhibitors of SHP2 tyrosine phosphatase discovered by virtual screening (Q33931319) (← links)
- Tyrosine phosphatases Shp1 and Shp2 have unique and opposing roles in oligodendrocyte development (Q34007299) (← links)
- Therapeutic potential of targeting the oncogenic SHP2 phosphatase (Q34061302) (← links)
- Identification of cryptotanshinone as an inhibitor of oncogenic protein tyrosine phosphatase SHP2 (PTPN11). (Q34155125) (← links)
- SHP-2 phosphatase activity is required for PECAM-1-dependent cell motility (Q34211722) (← links)
- Shp2 activates Fyn and Ras to regulate RBL-2H3 mast cell activation following FcεRI aggregation (Q34339747) (← links)
- Mechanical activation of mammalian target of rapamycin pathway is required for cartilage development (Q34365539) (← links)
- Targeting the PDGF signaling pathway in tumor treatment (Q34393461) (← links)
- LEOPARD syndrome-associated SHP2 mutation confers leanness and protection from diet-induced obesity (Q34409247) (← links)
- Shp2 suppresses PyMT-induced transformation in mouse fibroblasts by inhibiting Stat3 activity (Q34433715) (← links)
- Disorders of dysregulated signal traffic through the RAS-MAPK pathway: phenotypic spectrum and molecular mechanisms (Q34440570) (← links)
- Novel functions of the phosphatase SHP2 in the DNA replication and damage checkpoints (Q34493945) (← links)
- Inhibition of SHP2-mediated dephosphorylation of Ras suppresses oncogenesis (Q34503441) (← links)
- CD44: target for antiangiogenesis therapy (Q34570309) (← links)
- Development of severe skeletal defects in induced SHP-2-deficient adult mice: a model of skeletal malformation in humans with SHP-2 mutations (Q34611774) (← links)
- MiR-376c down-regulation accelerates EGF-dependent migration by targeting GRB2 in the HuCCT1 human intrahepatic cholangiocarcinoma cell line (Q34902779) (← links)
- PDGF-induced vascular smooth muscle cell proliferation is associated with dysregulation of insulin receptor substrates (Q35055601) (← links)
- Prolactin-stimulated activation of ERK1/2 mitogen-activated protein kinases is controlled by PI3-kinase/Rac/PAK signaling pathway in breast cancer cells (Q35165105) (← links)
- SHP2 phosphatase promotes mast cell chemotaxis toward stem cell factor via enhancing activation of the Lyn/Vav/Rac signaling axis (Q35248010) (← links)
- Glycogen synthase kinase-3β is a prosurvival signal for the maintenance of human mast cell homeostasis (Q35566591) (← links)
- Tyrosine phosphatase SHP-2 mediates C-type lectin receptor-induced activation of the kinase Syk and anti-fungal TH17 responses (Q35630243) (← links)
- The JAK inhibitor AZD1480 regulates proliferation and immunity in Hodgkin lymphoma. (Q35664956) (← links)
- T cell activation is reduced by the catalytically inactive form of protein tyrosine phosphatase SHP-2 (Q35791560) (← links)
- Noonan syndrome-causing SHP2 mutants inhibit insulin-like growth factor 1 release via growth hormone-induced ERK hyperactivation, which contributes to short stature. (Q35837138) (← links)
- Transcriptional hallmarks of Noonan syndrome and Noonan-like syndrome with loose anagen hair. (Q35903618) (← links)
- Gab1 mediates hepatocyte growth factor-stimulated mitogenicity and morphogenesis in multipotent myeloid cells. (Q36086815) (← links)
- SH2 Domain-Containing Phosphatase 2 Is a Critical Regulator of Connective Tissue Mast Cell Survival and Homeostasis in Mice (Q36155130) (← links)
- Role of SHP2 phosphatase in KIT-induced transformation: identification of SHP2 as a druggable target in diseases involving oncogenic KIT. (Q36286876) (← links)
- PECAM-1 isoforms, eNOS and endoglin axis in regulation of angiogenesis (Q36473318) (← links)
- The Shp2-induced epithelial disorganization defect is reversed by HDAC6 inhibition independent of Cdc42 (Q36528106) (← links)
- Shp2 Associates with and Enhances Nephrin Tyrosine Phosphorylation and Is Necessary for Foot Process Spreading in Mouse Models of Podocyte Injury. (Q36574874) (← links)
- Epithelial tyrosine phosphatase SHP-2 protects against intestinal inflammation in mice (Q36827092) (← links)
- 5,8-Dimethoxy-2-Nonylamino-Naphthalene-1,4-Dione Inhibits Vascular Smooth Muscle Cell Proliferation by Blocking Autophosphorylation of PDGF-Receptor β. (Q36927539) (← links)
- Age-dependent germline mosaicism of the most common noonan syndrome mutation shows the signature of germline selection (Q36929566) (← links)
- Tegumentary manifestations of Noonan and Noonan-related syndromes. (Q37119080) (← links)
- Deletion of SHP-2 in mesenchymal stem cells causes growth retardation, limb and chest deformity, and calvarial defects in mice (Q37287463) (← links)